[go: up one dir, main page]

MXPA03002122A - Metodos para inhibir disminucion en flujo de farmaco transdermico mediante inhibicion de cierre de trayectoria. - Google Patents

Metodos para inhibir disminucion en flujo de farmaco transdermico mediante inhibicion de cierre de trayectoria.

Info

Publication number
MXPA03002122A
MXPA03002122A MXPA03002122A MXPA03002122A MXPA03002122A MX PA03002122 A MXPA03002122 A MX PA03002122A MX PA03002122 A MXPA03002122 A MX PA03002122A MX PA03002122 A MXPA03002122 A MX PA03002122A MX PA03002122 A MXPA03002122 A MX PA03002122A
Authority
MX
Mexico
Prior art keywords
agent
inhibiting
inhibition
decrease
methods
Prior art date
Application number
MXPA03002122A
Other languages
English (en)
Inventor
A Johnson Juanita
Original Assignee
Johnson & Johnson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson filed Critical Johnson & Johnson
Publication of MXPA03002122A publication Critical patent/MXPA03002122A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Medical Informatics (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Surgical Instruments (AREA)
  • Media Introduction/Drainage Providing Device (AREA)

Abstract

Esta invencion se relaciona con un metodo para inhibir una disminucion en el flujo transdermico de un agente que esta siendo suministrado o muestreado transdermicamente durante un periodo prolongado, en donde el suministro o muestreo involucra la ruptura de por lo menos la capa cornea de la piel para formar rutas a traves de las cuales pasa el agente; el resultado deseado se logra al cosuministrar o comuestrear el agente con una cantidad de por lo menos un agente anticicatrizacion, en donde la cantidad del agente anticicatrizacion es efectiva para inhibir una disminucion en el flujo transdermico del agente comparado con el suministro o muestreo del agente bajo condiciones substancialmente identicas, excepto en la ausencia del (los) agente(s) anticicatrizacion.
MXPA03002122A 2000-09-08 2001-09-06 Metodos para inhibir disminucion en flujo de farmaco transdermico mediante inhibicion de cierre de trayectoria. MXPA03002122A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23116000P 2000-09-08 2000-09-08
PCT/US2001/027551 WO2002019985A2 (en) 2000-09-08 2001-09-06 Methods for inhibiting decrease in transdermal drug flux by inhibition of pathway closure

Publications (1)

Publication Number Publication Date
MXPA03002122A true MXPA03002122A (es) 2004-09-10

Family

ID=22867983

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03002122A MXPA03002122A (es) 2000-09-08 2001-09-06 Metodos para inhibir disminucion en flujo de farmaco transdermico mediante inhibicion de cierre de trayectoria.

Country Status (24)

Country Link
US (1) US7438926B2 (es)
EP (1) EP1335711B1 (es)
JP (2) JP5507030B2 (es)
KR (1) KR100764699B1 (es)
CN (1) CN100421653C (es)
AT (1) ATE367805T1 (es)
AU (2) AU8877401A (es)
BR (1) BR0113749A (es)
CA (1) CA2422200A1 (es)
CZ (1) CZ2003687A3 (es)
DE (1) DE60129585T2 (es)
DK (1) DK1335711T3 (es)
EE (1) EE200300095A (es)
ES (1) ES2290166T3 (es)
IL (1) IL154811A0 (es)
MA (1) MA25958A1 (es)
MX (1) MXPA03002122A (es)
NO (1) NO20031071L (es)
NZ (1) NZ524646A (es)
PL (1) PL365603A1 (es)
PT (1) PT1335711E (es)
RU (1) RU2272618C2 (es)
WO (1) WO2002019985A2 (es)
ZA (1) ZA200302700B (es)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002019985A2 (en) * 2000-09-08 2002-03-14 Alza Corporation Methods for inhibiting decrease in transdermal drug flux by inhibition of pathway closure
MXPA03003815A (es) * 2000-10-26 2004-08-12 Johnson & Johnson Dispositivos de suministro transdermico de farmaco que tienen microrresaltos recubiertos.
US6908453B2 (en) * 2002-01-15 2005-06-21 3M Innovative Properties Company Microneedle devices and methods of manufacture
WO2005004842A2 (en) 2003-06-30 2005-01-20 Alza Corporation Formulations for coated microprojections containing non-volatile counterions
EP1643918A1 (en) * 2003-07-02 2006-04-12 Alza Corporation Microprojection array immunization patch and method
AU2004268616B2 (en) 2003-08-25 2010-10-07 3M Innovative Properties Company Delivery of immune response modifier compounds
JP2007519613A (ja) * 2003-10-23 2007-07-19 アルザ・コーポレーシヨン 微小突出部をコーティングするための安定化されたｄｎａの組成物
JP2007510445A (ja) * 2003-10-24 2007-04-26 アルザ・コーポレーシヨン 経皮薬剤送達促進用の前処置法及びシステム
US20050106209A1 (en) * 2003-11-13 2005-05-19 Mahmoud Ameri Composition and apparatus for transdermal delivery
US20050220854A1 (en) 2004-04-01 2005-10-06 Yuh-Fun Maa Apparatus and method for transdermal delivery of influenza vaccine
CN101120101A (zh) * 2004-04-13 2008-02-06 阿尔扎公司 多联疫苗透皮释放的装置和方法
JP2007532645A (ja) * 2004-04-13 2007-11-15 アルザ コーポレイション フェンタニルに基づく薬剤の経皮送達システム用の器具および方法
CN101232874A (zh) * 2004-08-11 2008-07-30 阿尔扎公司 透皮递送利钠肽的装置和方法
US8057842B2 (en) 2004-11-18 2011-11-15 3M Innovative Properties Company Method of contact coating a microneedle array
KR101246015B1 (ko) 2004-11-18 2013-03-20 쓰리엠 이노베이티브 프로퍼티즈 컴파니 마이크로니들 어레이를 접촉 코팅하는 방법
WO2006055799A1 (en) * 2004-11-18 2006-05-26 3M Innovative Properties Company Masking method for coating a microneedle array
CN101160117A (zh) * 2005-02-16 2008-04-09 阿尔扎公司 依泊汀-基药物的透皮释放装置和方法
US20070270738A1 (en) * 2005-04-25 2007-11-22 Wu Jeffrey M Method of treating ACNE with stratum corneum piercing patch
US20060253079A1 (en) * 2005-04-25 2006-11-09 Mcdonough Justin Stratum corneum piercing device
WO2007002523A2 (en) * 2005-06-24 2007-01-04 3M Innovative Properties Company Collapsible patch with microneedle array
US20070078414A1 (en) * 2005-08-05 2007-04-05 Mcallister Devin V Methods and devices for delivering agents across biological barriers
CA2629193C (en) * 2005-11-18 2016-03-29 3M Innovative Properties Company Coatable compositions, coatings derived therefrom and microarrays having such coatings
EP2018835B1 (de) * 2007-07-09 2014-03-05 Augustinus Bader Wirkstoff abgebendes Pflaster
US8617487B2 (en) 2009-03-25 2013-12-31 Venture Lending & Leasing Vi, Inc. Saliva sample collection systems
US20120135955A1 (en) * 2009-07-24 2012-05-31 The University Of Tokyo External Preparation Containing NSAIDs And Method For Producing The External Preparation
EP2818159A1 (de) * 2013-06-25 2014-12-31 LTS LOHMANN Therapie-Systeme AG Vorrichtung mit transdermalem therapeutischem System, Positionier- und Penetrationshilfe
US9987361B1 (en) * 2014-12-29 2018-06-05 Noven Pharmaceuticals, Inc. Compositions and method for sustained drug delivery by active transdermal technology
DE102017126501A1 (de) 2017-11-10 2019-05-16 Lts Lohmann Therapie-Systeme Ag Mikronadelsystem zur Applikation eines Hepatitis-Impfstoffes
US20190231925A1 (en) * 2018-01-31 2019-08-01 Changchun Ja Biotech. Co., Ltd. Heparin sodium supported hydrogel sustained-release paster

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE25637E (en) 1964-09-08 Means for vaccinating
US3964482A (en) 1971-05-17 1976-06-22 Alza Corporation Drug delivery device
BE795384A (fr) 1972-02-14 1973-08-13 Ici Ltd Pansements
EP0429842B1 (en) * 1989-10-27 1996-08-28 Korea Research Institute Of Chemical Technology Device for the transdermal administration of protein or peptide drug
US5279544A (en) 1990-12-13 1994-01-18 Sil Medics Ltd. Transdermal or interdermal drug delivery devices
GB9118028D0 (en) * 1991-08-21 1991-10-09 Secr Defence Brit Improved transdrmal formulations
IL109037A (en) * 1993-03-19 1999-01-26 Cellegy Pharma Inc Preparations for causing phase separation of lipid layers and preparation of the above preparations
US5885211A (en) 1993-11-15 1999-03-23 Spectrix, Inc. Microporation of human skin for monitoring the concentration of an analyte
US5458140A (en) 1993-11-15 1995-10-17 Non-Invasive Monitoring Company (Nimco) Enhancement of transdermal monitoring applications with ultrasound and chemical enhancers
CA2205444A1 (en) * 1994-12-09 1996-06-13 Novartis Ag Transdermal system
AU5869796A (en) 1995-05-22 1996-12-11 Ned A. Godshall Micromechanical patch for enhancing the delivery of compound s through the skin
WO1996037155A1 (en) 1995-05-22 1996-11-28 Silicon Microdevices, Inc. Micromechanical device and method for enhancing delivery of compounds through the skin
DE19525607A1 (de) * 1995-07-14 1997-01-16 Boehringer Ingelheim Kg Transcorneales Arzneimittelfreigabesystem
US5902603A (en) * 1995-09-14 1999-05-11 Cygnus, Inc. Polyurethane hydrogel drug reservoirs for use in transdermal drug delivery systems, and associated methods of manufacture and use
DE19541260A1 (de) * 1995-11-06 1997-05-07 Lohmann Therapie Syst Lts Therapeutische Zubereitung zur transdermalen Applikation von Wirkstoffen durch die Haut
EP0914178B1 (en) 1996-06-18 2003-03-12 Alza Corporation Device for enhancing transdermal agent delivery or sampling
AU3880697A (en) 1996-07-03 1998-01-21 Altea Technologies, Inc. Multiple mechanical microporation of skin or mucosa
JP4054381B2 (ja) 1996-09-17 2008-02-27 デカ・プロダクツ・リミテッド・パートナーシップ 移送による薬伝達システム
ATE234649T1 (de) 1996-12-20 2003-04-15 Alza Corp Vorrichtung und verfahren zur erhöhung des transdermalen wirkstoffeflusses
DE19654391A1 (de) 1996-12-27 1998-07-02 Basf Ag Katalysator zur selektiven Herstellung von Propylen aus Propan
DK1314400T3 (da) * 1996-12-31 2007-10-15 Altea Therapeutics Corp Mikroporering af væv til levering af bioaktive midler
US6918901B1 (en) * 1997-12-10 2005-07-19 Felix Theeuwes Device and method for enhancing transdermal agent flux
CA2313458C (en) * 1997-12-11 2007-04-17 Alza Corporation Device for enhancing transdermal agent flux
EP1037686B1 (en) * 1997-12-11 2005-08-17 Alza Corporation Device for enhancing transdermal agent flux
KR100557261B1 (ko) * 1997-12-11 2006-03-07 알자 코포레이션 경피성 작용제 유동률을 증진시키기 위한 장치
US6022316A (en) 1998-03-06 2000-02-08 Spectrx, Inc. Apparatus and method for electroporation of microporated tissue for enhancing flux rates for monitoring and delivery applications
AU767122B2 (en) 1998-06-10 2003-10-30 Georgia Tech Research Corporation Microneedle devices and methods of manufacture and use thereof
CA2372919A1 (en) * 1999-05-17 2000-11-23 Kevin S. Machitto Remote and local controlled delivery of pharmaceutical compounds using electromagnetic energy
EP1187653B1 (en) * 1999-06-04 2010-03-31 Georgia Tech Research Corporation Devices for enhanced microneedle penetration of biological barriers
HK1048604B (en) * 1999-12-10 2006-05-04 Alza Corporation Device and method for enhancing microprotrusion skin piercing
HK1048773B (en) * 1999-12-10 2005-10-14 Alza Corporation Skin treatment device for continuous drug delivery through skin
WO2002019985A2 (en) * 2000-09-08 2002-03-14 Alza Corporation Methods for inhibiting decrease in transdermal drug flux by inhibition of pathway closure
MXPA03003815A (es) * 2000-10-26 2004-08-12 Johnson & Johnson Dispositivos de suministro transdermico de farmaco que tienen microrresaltos recubiertos.
AU2003275301A1 (en) * 2002-09-30 2004-04-23 Alza Corporation Drug delivery device having coated microprojections incorporating vasoconstrictors

Also Published As

Publication number Publication date
US20020102292A1 (en) 2002-08-01
MA25958A1 (fr) 2003-12-31
WO2002019985A2 (en) 2002-03-14
AU8877401A (en) 2002-03-22
JP2004508319A (ja) 2004-03-18
CA2422200A1 (en) 2002-03-14
JP2013256500A (ja) 2013-12-26
NO20031071D0 (no) 2003-03-07
BR0113749A (pt) 2004-06-22
JP5507030B2 (ja) 2014-05-28
ZA200302700B (en) 2004-08-13
WO2002019985A3 (en) 2002-09-06
ATE367805T1 (de) 2007-08-15
EP1335711A2 (en) 2003-08-20
DE60129585D1 (de) 2007-09-06
EP1335711B1 (en) 2007-07-25
IL154811A0 (en) 2003-10-31
US7438926B2 (en) 2008-10-21
DE60129585T2 (de) 2008-04-17
PT1335711E (pt) 2007-09-05
CN1473037A (zh) 2004-02-04
ES2290166T3 (es) 2008-02-16
KR100764699B1 (ko) 2007-10-08
CZ2003687A3 (cs) 2004-01-14
CN100421653C (zh) 2008-10-01
PL365603A1 (en) 2005-01-10
DK1335711T3 (da) 2007-11-26
AU2001288774B2 (en) 2006-06-29
RU2272618C2 (ru) 2006-03-27
NZ524646A (en) 2004-10-29
EE200300095A (et) 2005-02-15
NO20031071L (no) 2003-05-06
KR20030074595A (ko) 2003-09-19

Similar Documents

Publication Publication Date Title
IL154811A0 (en) Methods for inhibiting decrease in transdermal drug flux by inhibition of pathway closure
AU2003216321A1 (en) Tamper-resistant transdermal opioid delivery devices
WO2004006906A3 (en) Methods for the treatment of neoplasms
PL363079A1 (en) Transdermal patch for administering fentanyl
ES2017195A6 (es) Forma de dosificacion que tiene reducidas posiblidades de abuso.
WO2003032914A3 (en) Methods for treating substance abuse with cholinesterase inhibitors
WO2005018677A3 (en) Use of combination of an epidermal growth factor receptor kinase inhibitor and cytotoxic agents for treatment and inhibition of cancer
MXPA05003501A (es) Metodos para tratamiento del dolor administrando un antagonista del factor de crecimiento del nervio y un analgesico opioide y composiciones que los contienen.
WO2002049630A3 (en) Method for preventing or treating pain by administering an endothelin antagonist
TW200605929A (en) Method and apparatus for reducing the incidence of tobacco use
WO2001068125A3 (en) Methods and compositions for the treatment and prevention of erectile dysfunction
WO2001087343A3 (en) Combination therapy using cox-2 selective inhibitor and thromboxane inhibitor and compositions therefor
WO2007143185A3 (en) Transdermal treatment of tendinopathy using glyceryl trinitrite
EP1108426A3 (en) Use of prostaglandin agonists to treat erectile dysfunction or impotence
MX2007005065A (es) Forma de dosis de tiempo de retraso de farmacos para la terapia de insomnio.
WO2006047392A3 (en) Nicotinic-opioid synergy for analgesia
EP1441718A4 (en) CARBINOL FOR THE TREATMENT OF NEUROPATHIC FUNCTIONAL DISORDER
WO2007103190A3 (en) Transdermal treatment of tendinop athy using no donor
GEP201606538B (en) Preoperative treatment of post operative pain
ATE372126T1 (de) Spüllösung und verfahren zur schmerzlinderung und entzündungshemmung
WO2003101380A3 (en) Amyotrophic lateral sclerosis treatment with cyclooxygenase-2 inhibitors
TW200633720A (en) Medicinal composition for diabetic
WO2001000191A3 (en) Use of fosphenytion for the treatment of acute neuropathic pain
AU2002228314A1 (en) Means for retaining transcutaneous catheters and needles in place
WO2000023061A3 (en) Irrigation solution and method for inhibition of pain and inflammation

Legal Events

Date Code Title Description
FG Grant or registration